文献速递肿瘤 PET/CT骨显像与常规 SPECT核素与放射性配体治疗

68Ga-DOTA-IBA PET/CT与18F-FDG PET/CT在尤文肉瘤中的应用

68 Ga-DOTA-IBA PET/CT and 18 F-FDG PET/CT in Ewing Sarcoma.
PubMed 文献 · Clin Nucl Med · 2024-08-05

一例29岁男性右踝尤文肉瘤患者接受68Ga-DOTA-IBA PET/CT与18F-FDG PET/CT检查,两种显像均显示原发肿瘤高摄取;68Ga-DOTA-IBA PET/CT早期检出第六胸椎骨转移,18F-FDG PET/CT检出双侧肱骨转移;68Ga-DOTA-IBA在原发和转移灶中摄取均更高;177Lu-DOTA-IBA可能为转移性或复发性尤文肉瘤的治疗选择之一。

要点

  • 68Ga-DOTA-IBA PET/CT与18F-FDG PET/CT均显示尤文肉瘤原发灶高放射性摄取。
  • 68Ga-DOTA-IBA PET/CT早期检出第六胸椎骨转移,18F-FDG PET/CT检出双侧肱骨转移。
  • 68Ga-DOTA-IBA在原发和转移灶中摄取均高于18F-FDG,177Lu-DOTA-IBA可能用于转移或复发尤文肉瘤。

核心结论

  • 68Ga-DOTA-IBA在原发和转移灶中摄取均高于18F-FDG,177Lu-DOTA-IBA可能是转移性或复发性尤文肉瘤的潜在治疗选择之一。

研究设计与样本

  • 一例29岁男性右踝尤文肉瘤患者的病例报告,接受68Ga-DOTA-IBA PET/CT和18F-FDG PET/CT显像。

主要发现

  • 68Ga-DOTA-IBA PET/CT和18F-FDG PET/CT均显示原发肿瘤高放射性摄取。
  • 68Ga-DOTA-IBA PET/CT早期检出第六胸椎骨转移,18F-FDG PET/CT检出双侧肱骨转移。
  • 68Ga-DOTA-IBA在原发和转移部位的摄取均高于18F-FDG。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 29-year-old man with Ewing sarcoma in the right ankle underwent 68 Ga-DOTA-IBA PET/CT and 18 F-FDG PET/CT, both of which showed high radiotracer activity for the primary tumor. Interestingly, bone metastases were detected early using 68 Ga-DOTA-IBA PET/CT for the sixth thoracic vertebrae and with 18 F-FDG PET/CT for the bilateral humerus. Higher uptake of 68 Ga-DOTA-IBA was found in both primary and metastatic sites of Ewing sarcoma. 177 Lu-DOTA-IBA may be one of the possible therapies for metastatic or recurrent Ewing sarcoma.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Xiang F, Liu H, Tan X, et al. 68 Ga-DOTA-IBA PET/CT and 18 F-FDG PET/CT in Ewing Sarcoma. Clin Nucl Med. 2024. PMID: 39104035. doi:10.1097/RLU.0000000000005402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。